The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) |
93.395, 93.399 |
PAR-19-352 |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) |
93.393, 93.395 |
PAR-19-358 |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) |
93.393, 93.395 |
PAR-19-360 |
| Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional) |
93.395, 93.399 |
PAR-19-355 |
| Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) |
93.396 |
PAR-19-353 |
| Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) |
93.396 |
PAR-19-354 |
| NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399 |
PAR-19-356 |
| Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed) |
93.855 |
PAR-19-351 |
| Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) |
93.399 |
PAR-19-350 |
| Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) |
93.399 |
PAR-19-348 |
| Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed) |
93.855 |
PAR-19-347 |
| NIDA Program Project Grant Applications (P01 Clinical Trial Optional) |
93.279 |
PAR-19-345 |
| NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) |
93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399 |
PAR-19-349 |
| Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) |
93.855 |
PAR-19-346 |
| Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed) |
93.859 |
PAR-19-343 |
| Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) |
93.121, 93.173, 93.233, 93.242, 93.350, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.856, 93.866, 93.867 |
RFA-HL-20-030 |
| Hazardous Materials Worker Health and Safety Training (U45 Clinical Trial Not Allowed) |
93.142 |
RFA-ES-19-003 |
| Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) |
93.859 |
PAR-19-342 |
| Research Education: Short Courses on Alzheimer's Disease and Related Dementias for the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-031 |
| Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Linked to Behavior (R01 Clinical Trial Optional) |
93.242 |
PAR-19-344 |
| NEA Sound Health Network, FY2020 |
45.024 |
NEAPS1903 |
| HAZMAT Training at DOE Nuclear Weapons Complex (UH4 Clinical Trial Not Allowed) |
93.142 |
RFA-ES-19-004 |
| Ending the HIV Epidemic: A Plan for America - Ryan White HIV/AIDS Program Parts A and B |
93.686 |
HRSA-20-078 |
| Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) |
93.395 |
PAR-19-339 |
| Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) |
93.395 |
PAR-19-340 |
| Circadian Patterns of Gene Expression Associated with Disease (R01 - Clinical Trial Optional) |
93.233, 93.279, 93.837, 93.838, 93.839 |
RFA-HL-20-016 |
| Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Early-onset Alzheimers Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed) |
93.866 |
PAR-19-338 |
| Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional) |
93.350 |
PAR-19-337 |
| The Biological Mechanisms of Metformin Effects on Aging and Longevity (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-044 |
| Technologies to Advance Precision Medicine Diagnosis and Treatment of Infertility, Reproductive Tract and Gynecologic Disorders Affecting Fertility (R43/R44 Clinical Trial Optional) |
93.865 |
RFA-HD-20-010 |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed |
93.121, 93.173, 93.233, 93.242, 93.273, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.866, 93.867 |
PAR-19-333 |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed |
93.113, 93.121, 93.172, 93.173, 93.233, 93.242, 93.273, 93.286, 93.350, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.859, 93.866, 93.867 |
PAR-19-334 |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Required |
93.173, 93.233, 93.242, 93.273, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866, 93.867 |
PAR-19-335 |
| Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-19-330 |
| Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) |
93.233, 93.340, 93.837, 93.838, 93.839 |
PAR-19-329 |
| Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-19-328 |
| Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) |
93.279 |
PAR-19-327 |
| US Children with Perinatal HIV who were Born Internationally (R01 Clinical Trial Optional) |
93.865 |
RFA-HD-20-006 |
| Palliative Care in Home and Community Settings (R01 Clinical Trial Optional) |
93.361 |
PAR-19-321 |
| Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional) |
93.242, 93.279, 93.989 |
PAR-19-326 |
Search Results 3321-3360 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
